In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...